<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Emery-Dreifuss <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EDMD</z:e>) is a hereditary <z:e sem="disease" ids="C0027868" disease_type="Disease or Syndrome" abbrv="">neuromuscular disorder</z:e> characterized by <z:hpo ids='HP_0003677'>slowly progressive</z:hpo> <z:hpo ids='HP_0001324'>muscle weakness</z:hpo>, early <z:hpo ids='HP_0001371'>contractures</z:hpo>, and <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We reported an uneventful general anaesthesia using total intravenous anaesthesia (TIVA) for cardiac transplantation in a 19-year-old woman suffering from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EDMD</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In vitro <z:hpo ids='HP_0001371'>contracture</z:hpo> test results of two pectoralis major muscle bundles of the patient suggest that exposition to triggering agents does not induce a pathological sarcoplasmic calcium release in the lamin A/C phenotype </plain></SENT>
<SENT sid="3" pm="."><plain>However, due to the lack of evidence in the literature, we would recommend TIVA for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EDMD</z:e> if general anaesthesia is required </plain></SENT>
</text></document>